APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brompheniramine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Brompheniramine Industry Growth and Trends Forecast to 2032

19 December 2025109 pages

Choose your research edition.

Industry ResearchBrompheniramine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Brompheniramine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Brompheniramine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brompheniramine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Brompheniramine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Brompheniramine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brompheniramine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brompheniramine include AMAG Pharmaceuticals, Endo International, Eon Pharma, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, PAI, Tanta Pharmaceuticals and USL Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Brompheniramine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brompheniramine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brompheniramine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brompheniramine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Brompheniramine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brompheniramine Market by Company

AMAG Pharmaceuticals

Endo International

Eon Pharma

Ivax Pharmaceuticals

Newtron Pharmaceuticals

Nexgen Pharma

PAI

Tanta Pharmaceuticals

USL Pharma

Watson Laboratories

Pfizer

Merck

Novartis

Teva

Brompheniramine Segment by Type

Oral Solution

Tablet

Brompheniramine Segment by Application

Hospital

Drug Store

Brompheniramine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brompheniramine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brompheniramine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brompheniramine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brompheniramine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Brompheniramine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Solution Table 2. Major Company of Tablet Table 3. Global Brompheniramine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Brompheniramine Sales by Type (2021-2026) & (K Units) Table 5. Global Brompheniramine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Brompheniramine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Brompheniramine Sales Market Share in Value by Type (2021-2026) Table 8. Global Brompheniramine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Brompheniramine Sales by Type (2027-2032) & (K Units) Table 10. Global Brompheniramine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Brompheniramine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Brompheniramine Sales Market Share in Value by Type (2027-2032) Table 13. Global Brompheniramine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Brompheniramine Sales by Type (2021-2026) & (K Units) Table 15. North America Brompheniramine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Brompheniramine Sales by Type (2021-2026) & (K Units) Table 17. Europe Brompheniramine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Brompheniramine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Brompheniramine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Brompheniramine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Brompheniramine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Brompheniramine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Brompheniramine Sales by Type (2021-2026) & (US$ Million) Table 24. Brompheniramine Industry Trends Table 25. Brompheniramine Industry Drivers Table 26. Brompheniramine Industry Opportunities and Challenges Table 27. Brompheniramine Industry Restraints Table 28. Global Brompheniramine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Brompheniramine Revenue Market Share by Company (2021-2026) Table 30. Global Brompheniramine Sales by Company (2021-2026) & (K Units) Table 31. Global Brompheniramine Sales Share by Company (2021-2026) Table 32. Global Brompheniramine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Brompheniramine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Brompheniramine Major Company Production Sites and Headquarters Table 35. Global Brompheniramine Company, Product Type & Application Table 36. Global Brompheniramine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Brompheniramine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Brompheniramine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Brompheniramine Sales by Region (2021-2026) & (K Units) Table 41. Global Brompheniramine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Brompheniramine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Brompheniramine Sales Market Share in Value by Region (2021-2026) Table 44. Global Brompheniramine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Brompheniramine Sales by Region (2027-2032) & (K Units) Table 46. Global Brompheniramine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Brompheniramine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Brompheniramine Sales Market Share in Value by Region (2027-2032) Table 49. Global Brompheniramine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Brompheniramine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Brompheniramine Sales by Application (2021-2026) & (K Units) Table 52. Global Brompheniramine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Brompheniramine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Brompheniramine Sales Market Share in Value by Application (2021-2026) Table 55. Global Brompheniramine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Brompheniramine Sales by Application (2027-2032) & (K Units) Table 57. Global Brompheniramine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Brompheniramine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Brompheniramine Sales Market Share in Value by Application (2027-2032) Table 60. Global Brompheniramine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Brompheniramine Sales by Application (2021-2026) & (K Units) Table 62. North America Brompheniramine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Brompheniramine Sales by Application (2021-2026) & (K Units) Table 64. Europe Brompheniramine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Brompheniramine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Brompheniramine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Brompheniramine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Brompheniramine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Brompheniramine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Brompheniramine Sales by Application (2021-2026) & (US$ Million) Table 71. AMAG Pharmaceuticals Company Information Table 72. AMAG Pharmaceuticals Business Overview Table 73. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AMAG Pharmaceuticals Brompheniramine Product Portfolio Table 75. AMAG Pharmaceuticals Recent Development Table 76. Endo International Company Information Table 77. Endo International Business Overview Table 78. Endo International Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Endo International Brompheniramine Product Portfolio Table 80. Endo International Recent Development Table 81. Eon Pharma Company Information Table 82. Eon Pharma Business Overview Table 83. Eon Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eon Pharma Brompheniramine Product Portfolio Table 85. Eon Pharma Recent Development Table 86. Ivax Pharmaceuticals Company Information Table 87. Ivax Pharmaceuticals Business Overview Table 88. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ivax Pharmaceuticals Brompheniramine Product Portfolio Table 90. Ivax Pharmaceuticals Recent Development Table 91. Newtron Pharmaceuticals Company Information Table 92. Newtron Pharmaceuticals Business Overview Table 93. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Newtron Pharmaceuticals Brompheniramine Product Portfolio Table 95. Newtron Pharmaceuticals Recent Development Table 96. Nexgen Pharma Company Information Table 97. Nexgen Pharma Business Overview Table 98. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Nexgen Pharma Brompheniramine Product Portfolio Table 100. Nexgen Pharma Recent Development Table 101. PAI Company Information Table 102. PAI Business Overview Table 103. PAI Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. PAI Brompheniramine Product Portfolio Table 105. PAI Recent Development Table 106. Tanta Pharmaceuticals Company Information Table 107. Tanta Pharmaceuticals Business Overview Table 108. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Tanta Pharmaceuticals Brompheniramine Product Portfolio Table 110. Tanta Pharmaceuticals Recent Development Table 111. USL Pharma Company Information Table 112. USL Pharma Business Overview Table 113. USL Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. USL Pharma Brompheniramine Product Portfolio Table 115. USL Pharma Recent Development Table 116. Watson Laboratories Company Information Table 117. Watson Laboratories Business Overview Table 118. Watson Laboratories Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Watson Laboratories Brompheniramine Product Portfolio Table 120. Watson Laboratories Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Pfizer Brompheniramine Product Portfolio Table 125. Pfizer Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Merck Brompheniramine Product Portfolio Table 130. Merck Recent Development Table 131. Novartis Company Information Table 132. Novartis Business Overview Table 133. Novartis Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Novartis Brompheniramine Product Portfolio Table 135. Novartis Recent Development Table 136. Teva Company Information Table 137. Teva Business Overview Table 138. Teva Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Teva Brompheniramine Product Portfolio Table 140. Teva Recent Development Table 141. North America Brompheniramine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Brompheniramine Sales by Country (2021-2026) & (K Units) Table 143. North America Brompheniramine Sales Market Share by Country (2021-2026) Table 144. North America Brompheniramine Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Brompheniramine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Brompheniramine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Brompheniramine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Brompheniramine Market Share by Country (2021-2026) Table 149. North America Brompheniramine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Brompheniramine Market Share Forecast by Country (2027-2032) Table 151. Europe Brompheniramine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Brompheniramine Sales by Country (2021-2026) & (K Units) Table 153. Europe Brompheniramine Sales Market Share by Country (2021-2026) Table 154. Europe Brompheniramine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Brompheniramine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Brompheniramine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Brompheniramine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Brompheniramine Market Share by Country (2021-2026) Table 159. Europe Brompheniramine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Brompheniramine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Brompheniramine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Brompheniramine Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Brompheniramine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Brompheniramine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Brompheniramine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Brompheniramine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Brompheniramine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Brompheniramine Market Share by Country (2021-2026) Table 169. Asia-Pacific Brompheniramine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Brompheniramine Market Share Forecast by Country (2027-2032) Table 171. Latin America Brompheniramine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Brompheniramine Sales by Country (2021-2026) & (K Units) Table 173. Latin America Brompheniramine Sales Market Share by Country (2021-2026) Table 174. Latin America Brompheniramine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Brompheniramine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Brompheniramine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Brompheniramine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Brompheniramine Market Share by Country (2021-2026) Table 179. Latin America Brompheniramine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Brompheniramine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Brompheniramine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Brompheniramine Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Brompheniramine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Brompheniramine Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Brompheniramine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Brompheniramine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Brompheniramine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Brompheniramine Market Share by Country (2021-2026) Table 189. Middle East and Africa Brompheniramine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Brompheniramine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Brompheniramine Distributors List Table 194. Brompheniramine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Brompheniramine Image Figure 2. Global Brompheniramine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brompheniramine Market Size (2021-2032) & (US$ Million) Figure 4. Global Brompheniramine Sales (2021-2032) & (K Units) Figure 5. Oral Solution Image Figure 6. Global Oral Solution Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Brompheniramine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Brompheniramine Market Share by Type 2025 VS 2032 Figure 11. North America Brompheniramine Sales Market Share in Volume by Type in 2025 Figure 12. North America Brompheniramine Sales Market Share in Value by Type in 2025 Figure 13. Europe Brompheniramine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Brompheniramine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Brompheniramine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Brompheniramine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Brompheniramine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Brompheniramine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Brompheniramine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Brompheniramine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Brompheniramine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Brompheniramine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Brompheniramine Market Share by Application 2025 VS 2032 Figure 29. North America Brompheniramine Sales Market Share in Volume by Application in 2025 Figure 30. North America Brompheniramine Sales Market Share in Value by Application in 2025 Figure 31. Europe Brompheniramine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Brompheniramine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Brompheniramine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Brompheniramine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Brompheniramine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Brompheniramine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Brompheniramine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Brompheniramine Sales Market Share in Value by Application in 2025 Figure 39. North America Brompheniramine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Brompheniramine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Brompheniramine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Brompheniramine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Brompheniramine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Brompheniramine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Brompheniramine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Brompheniramine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Brompheniramine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Brompheniramine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Brompheniramine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Brompheniramine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Brompheniramine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Brompheniramine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Brompheniramine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Brompheniramine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Brompheniramine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Brompheniramine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Brompheniramine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Brompheniramine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Brompheniramine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Brompheniramine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solution
  • Tablet
Applications
  • Hospital
  • Drug Store
Companies covered
  • AMAG Pharmaceuticals
  • Endo International
  • Eon Pharma
  • Ivax Pharmaceuticals
  • Newtron Pharmaceuticals
  • Nexgen Pharma
  • PAI
  • Tanta Pharmaceuticals
  • USL Pharma
  • Watson Laboratories
  • Pfizer
  • Merck
  • Novartis
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brompheniramine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Brompheniramine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Brompheniramine Market by Type
  6. 1.3.1 Oral Solution
  7. 1.3.2 Tablet
  8. 1.4 Global Brompheniramine Market Size by Type
  9. 1.4.1 Global Brompheniramine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Brompheniramine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Brompheniramine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Brompheniramine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Brompheniramine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Brompheniramine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Brompheniramine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Brompheniramine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Brompheniramine Industry Trends
  2. 2.2 Brompheniramine Industry Drivers
  3. 2.3 Brompheniramine Industry Opportunities and Challenges
  4. 2.4 Brompheniramine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Brompheniramine Revenue (2021-2026)
  2. 3.2 Global Top Players by Brompheniramine Sales (2021-2026)
  3. 3.3 Global Top Players by Brompheniramine Price (2021-2026)
  4. 3.4 Global Brompheniramine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brompheniramine Major Company Production Sites & Headquarters
  6. 3.6 Global Brompheniramine Company, Product Type & Application
  7. 3.7 Global Brompheniramine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brompheniramine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brompheniramine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brompheniramine Tier 1, Tier 2, and Tier 3
4 Brompheniramine Regional Status and Outlook
  1. 4.1 Global Brompheniramine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Brompheniramine Historic Market Size by Region
  3. 4.2.1 Global Brompheniramine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Brompheniramine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Brompheniramine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Brompheniramine Forecasted Market Size by Region
  7. 4.3.1 Global Brompheniramine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Brompheniramine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Brompheniramine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Brompheniramine by Application
  1. 5.1 Brompheniramine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Brompheniramine Market Size by Application
  5. 5.2.1 Global Brompheniramine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Brompheniramine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Brompheniramine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Brompheniramine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Brompheniramine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Brompheniramine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Brompheniramine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Brompheniramine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AMAG Pharmaceuticals
  2. 6.1.1 AMAG Pharmaceuticals Company Information
  3. 6.1.2 AMAG Pharmaceuticals Business Overview
  4. 6.1.3 AMAG Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AMAG Pharmaceuticals Brompheniramine Product Portfolio
  6. 6.1.5 AMAG Pharmaceuticals Recent Developments
  7. 6.2 Endo International
  8. 6.2.1 Endo International Company Information
  9. 6.2.2 Endo International Business Overview
  10. 6.2.3 Endo International Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Endo International Brompheniramine Product Portfolio
  12. 6.2.5 Endo International Recent Developments
  13. 6.3 Eon Pharma
  14. 6.3.1 Eon Pharma Company Information
  15. 6.3.2 Eon Pharma Business Overview
  16. 6.3.3 Eon Pharma Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eon Pharma Brompheniramine Product Portfolio
  18. 6.3.5 Eon Pharma Recent Developments
  19. 6.4 Ivax Pharmaceuticals
  20. 6.4.1 Ivax Pharmaceuticals Company Information
  21. 6.4.2 Ivax Pharmaceuticals Business Overview
  22. 6.4.3 Ivax Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ivax Pharmaceuticals Brompheniramine Product Portfolio
  24. 6.4.5 Ivax Pharmaceuticals Recent Developments
  25. 6.5 Newtron Pharmaceuticals
  26. 6.5.1 Newtron Pharmaceuticals Company Information
  27. 6.5.2 Newtron Pharmaceuticals Business Overview
  28. 6.5.3 Newtron Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Newtron Pharmaceuticals Brompheniramine Product Portfolio
  30. 6.5.5 Newtron Pharmaceuticals Recent Developments
  31. 6.6 Nexgen Pharma
  32. 6.6.1 Nexgen Pharma Company Information
  33. 6.6.2 Nexgen Pharma Business Overview
  34. 6.6.3 Nexgen Pharma Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nexgen Pharma Brompheniramine Product Portfolio
  36. 6.6.5 Nexgen Pharma Recent Developments
  37. 6.7 PAI
  38. 6.7.1 PAI Company Information
  39. 6.7.2 PAI Business Overview
  40. 6.7.3 PAI Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PAI Brompheniramine Product Portfolio
  42. 6.7.5 PAI Recent Developments
  43. 6.8 Tanta Pharmaceuticals
  44. 6.8.1 Tanta Pharmaceuticals Company Information
  45. 6.8.2 Tanta Pharmaceuticals Business Overview
  46. 6.8.3 Tanta Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tanta Pharmaceuticals Brompheniramine Product Portfolio
  48. 6.8.5 Tanta Pharmaceuticals Recent Developments
  49. 6.9 USL Pharma
  50. 6.9.1 USL Pharma Company Information
  51. 6.9.2 USL Pharma Business Overview
  52. 6.9.3 USL Pharma Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 USL Pharma Brompheniramine Product Portfolio
  54. 6.9.5 USL Pharma Recent Developments
  55. 6.10 Watson Laboratories
  56. 6.10.1 Watson Laboratories Company Information
  57. 6.10.2 Watson Laboratories Business Overview
  58. 6.10.3 Watson Laboratories Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Watson Laboratories Brompheniramine Product Portfolio
  60. 6.10.5 Watson Laboratories Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Brompheniramine Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Brompheniramine Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Novartis
  74. 6.13.1 Novartis Company Information
  75. 6.13.2 Novartis Business Overview
  76. 6.13.3 Novartis Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Novartis Brompheniramine Product Portfolio
  78. 6.13.5 Novartis Recent Developments
  79. 6.14 Teva
  80. 6.14.1 Teva Company Information
  81. 6.14.2 Teva Business Overview
  82. 6.14.3 Teva Brompheniramine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Teva Brompheniramine Product Portfolio
  84. 6.14.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Brompheniramine Sales by Country
  2. 7.1.1 North America Brompheniramine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Brompheniramine Sales by Country (2021-2026)
  4. 7.1.3 North America Brompheniramine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Brompheniramine Market Size by Country
  6. 7.2.1 North America Brompheniramine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Brompheniramine Market Size by Country (2021-2026)
  8. 7.2.3 North America Brompheniramine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Brompheniramine Sales by Country
  2. 8.1.1 Europe Brompheniramine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Brompheniramine Sales by Country (2021-2026)
  4. 8.1.3 Europe Brompheniramine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Brompheniramine Market Size by Country
  6. 8.2.1 Europe Brompheniramine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Brompheniramine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Brompheniramine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Brompheniramine Sales by Country
  2. 9.1.1 Asia-Pacific Brompheniramine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Brompheniramine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Brompheniramine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Brompheniramine Market Size by Country
  6. 9.2.1 Asia-Pacific Brompheniramine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Brompheniramine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Brompheniramine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Brompheniramine Sales by Country
  2. 10.1.1 South America Brompheniramine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Brompheniramine Sales by Country (2021-2026)
  4. 10.1.3 South America Brompheniramine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Brompheniramine Market Size by Country
  6. 10.2.1 South America Brompheniramine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Brompheniramine Market Size by Country (2021-2026)
  8. 10.2.3 South America Brompheniramine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Brompheniramine Sales by Country
  2. 11.1.1 Middle East and Africa Brompheniramine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Brompheniramine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Brompheniramine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Brompheniramine Market Size by Country
  6. 11.2.1 Middle East and Africa Brompheniramine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Brompheniramine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Brompheniramine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Brompheniramine Value Chain Analysis
  2. 12.1.1 Brompheniramine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Brompheniramine Production Mode & Process
  7. 12.2 Brompheniramine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Brompheniramine Distributors
  10. 12.2.3 Brompheniramine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst